Management of the malignant colorectal polyp: ACPGBI position statement
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
A colorectal polyp is an abnormal protrusion of the mucosa into the bowel lumen that is classified by histopathological examination (Fig. 1). Adenomas are a common finding during colonoscopy in symptomatic patients and in asymptomatic individuals undergoing screening. It is estimated that the prevalence of large-bowel adenoma is 21–28% in 50–59-year-old subjects, increasing to 40–45% in 60–69-year-old subjects and rising further to 53–58% in people over the age of 70 1. Adenomas are important as they are the precursor lesion of most colorectal cancers arising through the adenoma–carcinoma sequence 2. This association is supported by epidemiological, clinical and molecular research 3. Whilst most polyps removed are small, it is well recognized that the risk of malignant transformation increases with increasing polyp size. There is compelling evidence that removing adenomas from the colon substantially reduces the risk of a patient developing colorectal cancer 4. The term 'malignant polyp' refers to an adenoma that appears benign macroscopically but in which there is invasion through the muscularis mucosae into the submucosa. Such a focus of carcinoma is detected on histological examination. A malignant polyp is therefore an early carcinoma. It accounts for 0.75–5.6% 5-9 of large-bowel polyps removed in general diagnostic colonoscopy practice. The wide discrepancy is explained by differences in the study populations, being lower where all polyps removed are histologically assessed and higher in series that only include larger polyps. In the Nottingham Bowel Cancer Screening Trial, 1466 patients underwent colonoscopy because of a positive faecal occult blood-test result. Of these, 710 (48%) were found to have an adenoma and a further 73 (5%) had an adenoma containing a focus of cancer 10. A similar incidence of malignant polyps has been found in the National Bowel Cancer Screening Programme. Of the first 1-million individuals screened, just over 17 000 had a positive faecal occult blood-test result. Of these, 1574 (9%) had cancer of which 155 (10%) were malignant polyps 11. In recent years, greater use of diagnostic colonoscopy has been accompanied by a rise in the number of malignant polyps removed endoscopically 12. The management of a malignant polyp following endoscopic removal is difficult because the possibility of residual malignant cells within the bowel wall or positive regional lymph nodes varies from patient to patient, depending on a number of prognostic factors. The evidence base for management of these lesions is poor and is mostly based on data from symptomatic patients 6, 13, 14. Advising patients on the course of action after removal is difficult. It includes surveillance only, where the risk of residual disease is deemed to be low, or major surgical resection for those with a higher risk. However, the level of risk is often difficult to calculate. Furthermore, the presence of comorbidity and the site of the lesion should also be considered when discussing further management with the patient. This position statement deals with a number of matters relating to the management of patients with a malignant polyp. It is divided into four sections. The first section considers colonoscopy and includes a discussion of endoscopic techniques for the removal of larger adenomas, which are more likely to be malignant. The influence of polypectomy technique on histopathological assessment and the regimens for postresection endoscopic surveillance are discussed. The second section reviews the histopathology of adenomas and polypoid carcinomas and considers important prognostic indicators. The third section deals with how the prognostic indicators influence the risk of residual cancer in the bowel wall or lymph nodes to estimate the likelihood of recurrence if no further treatment is undertaken. The traditional advice for a 'high-risk' adenoma was to advise a radical 'cancer' segmental colectomy, including the lympho-vascular pedicle. The fourth section discusses the balance of the risk of morbidity and mortality following endoscopic resection against the risk of recurrence and how this risk is communicated to the patient. Finally, the role of endoscopic and radiological imaging in the assessment and follow up of malignant polyps is considered, particularly where radical surgery is not performed. This also includes a discussion of the optimal follow-up protocol. Searches of the Cochrane Database, PubMed, MEDLINE and Embase were performed using keywords relevant to each section of the position statement. They were mostly limited to English-language articles. Additional publications were retrieved from references cited in articles identified from the primary search. All evidence was classified according to an accepted hierarchy of evidence, and recommendations were graded from A to C on the basis of the level of associated evidence and/or noted as Good Practice and/or part of the National Institutes of Clinical
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Peeters, K. C. M. J., Marijnen, C. A. M., Nagtegaal, I. D., Kranenbarg, E. K., Putter, H., Wiggers, T., Rutten, H., Pahlman, L., Glimelius, B., Leer, J. W., et al. (2007) · Annals of Surgery · doi:10.1097/01.sla.0000257358.56863.ce · Cited by 1,191
Risk factors for an adverse outcome in early invasive colorectal carcinoma
Ueno, H., Mochizuki, H., Hashiguchi, Y., Shimazaki, H., Aida, S., Hase, K., Matsukuma, S., Kanai, T., Kurihara, H., Ozawa, K., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.04.022 · Cited by 758
Kitajima, K., Fujimori, T., Fujii, S., Takeda, J., Ohkura, Y., Kawamata, H., Kumamoto, T., Ishiguro, S., Kato, Y., Shimoda, T., et al. (2004) · Journal of Gastroenterology · doi:10.1007/s00535-004-1339-4 · Cited by 663
Cited by
Ferlitsch, M., Moss, A., Hassan, C., Bhandari, P., Dumonceau, J.-M., Paspatis, G., Jover, R., Langner, C., Bronzwaer, M., Nalankilli, K., et al. (2017) · Endoscopy · doi:10.1055/s-0043-102569 · Cited by 1,108
Vogel, J. D., Felder, S. I., Bhama, A. R., Hawkins, A. T., Langenfeld, S. J., Shaffer, V. O., Thorsen, A. J., Weiser, M. R., Chang, G. J., Lightner, A. L., et al. (2022) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0000000000002323 · Cited by 401
van Bokhorst, Q. N., Houwen, B. B., Hazewinkel, Y., Fockens, P., & Dekker, E. (2023) · Endoscopy International Open · doi:10.1055/a-2098-1999 · Cited by 8
Metadata
- Authors
- Williams, J. G., Pullan, R. D., Hill, J., Horgan, P. G., Salmo, E., Buchanan, G. N., Rasheed, S., McGee, S. G., & Haboubi, N.
- Venue
- Colorectal Disease
- Publisher
- Wiley
- Published
- 2013-07-12
- Volume
- 15
- Issue
- s2
- Pages
- 1-38
- ISSN
- 1462-8910 (ISSN-L)
- 1463-1318
- OpenAlex
- W2032825860
- Cited by
- 187
- References
- 3
- FWCI
- 6.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.